PMID: 15379633Sep 24, 2004Paper

Heparin affin regulatory peptide: a new target for tumour therapy?

Current Cancer Drug Targets
E PapadimitriouC Mikelis

Abstract

Heparin affin regulatory peptide (HARP), also known as pleiotrophin or heparin-binding growth-associated molecule, is an 18-kDa growth factor that has a high affinity for heparin. It constitutes with midkine and retinoic acid heparin-binding protein, a family of structurally related heparin-binding growth factors. A growing body of evidence indicates that HARP is involved in the control of cellular proliferation, migration and differentiation and plays a significant role in tumor growth and angiogenesis. HARP has a well described role in physiological as well as tumor angiogenesis, and is detected in various carcinomas, such as human breast and prostate cancer, neuroblastomas, gliomas, benign meningiomas, small cell lung cancer and mammary tumors, exhibiting a proto-oncogene function. It is also constitutively expressed in tumour cell lines and is involved in tumour growth and metastasis. Therefore, HARP appears to be a potential new target for the treatment or/and diagnosis of several types of cancer.

Citations

May 20, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Yvonne Hui-Fang TengGeorge Wai-Cheong Yip
Jul 7, 2007·Expert Opinion on Therapeutic Targets·Rolf Mentlein
Jul 29, 2008·Connective Tissue Research·Constantinos Mikelis, Evangelia Papadimitriou
Sep 21, 2007·European Journal of Cell Biology·Anastasia ParthymouEvangelia Papadimitriou
Jun 1, 2005·The Prostate·Maria HatziapostolouEvangelia Papadimitriou
Dec 22, 2006·Journal of Neurochemistry·Ying TongJanka Held-Feindt
Mar 31, 2005·The Journal of Biological Chemistry·Apostolos PolykratisEvangelia Papadimitriou
Aug 31, 2006·The Journal of Biological Chemistry·Maria HatziapostolouEvangelia Papadimitriou
Apr 14, 2018·Scientific Reports·Evgenia LampropoulouEvangelia Papadimitriou
Mar 2, 2006·The Journal of Biological Chemistry·Gang LiHong Wu
Jan 14, 2017·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Xue DingMingwei Zhao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.